Zacks Small Cap Research on MSN
AEON: Initiating coverage – imitation is a sincere form of flattery: seeking a Botox biosimilar
By John Vandermosten, CFA NYSE: AEON READ THE FULL AEON RESEARCH REPORT We are initiating coverage of AEON Biopharma, Inc. (NYSE: AEON) with a valuation of $2.00 per share. This value is based on our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results